ChartRow logo
Data provided bySource: Twelve Data
PeersJNJAMGNABBVBMYNVSLLY
Share this page

MRK financial statements

The full income statement, balance sheet, and cash-flow statement for Merck & Co. Inc. (MRK), plus valuation ratios — straight from SEC filings. Switch between annual, quarterly, and trailing-twelve-month figures, pick how far back to look, and flip the time order. Every line has a trend sparkline.

Financial overview#

Revenue

5Y CAGR +9.4%5Y CAGR +9.4%YoY +4.7%
$67.4B TTM$18.1B Q3 '26
FY15FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25TTM
Q4 '16Q1 '17Q2 '17Q3 '17Q4 '17Q1 '18Q2 '18Q3 '18Q4 '18Q1 '19Q2 '19Q3 '19Q4 '19Q1 '20Q2 '20Q3 '20Q4 '20Q1 '21Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

Gross profit

5Y CAGR +11.8%5Y CAGR +11.8%YoY −1.7%
$48.3B TTM$13.2B Q3 '26
FY15FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25TTM
Q4 '16Q1 '17Q2 '17Q3 '17Q4 '17Q1 '18Q2 '18Q3 '18Q4 '18Q1 '19Q2 '19Q3 '19Q4 '19Q1 '20Q2 '20Q3 '20Q4 '20Q1 '21Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

Net income

5Y CAGR +20.9%10Y CAGR +15.2%YoY −12.4%
$2.5B TTM$5.1B Q3 '26
FY15FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25TTM
Q4 '16Q1 '17Q2 '17Q3 '17Q4 '17Q1 '18Q2 '18Q3 '18Q4 '18Q1 '19Q2 '19Q3 '19Q4 '19Q1 '20Q2 '20Q3 '20Q4 '20Q1 '21Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

EPS (diluted)

5Y CAGR +21.2%10Y CAGR +16.7%YoY −12.1%
$0.99 TTM$2.04 Q3 '26
FY15FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25TTM
Q4 '16Q1 '17Q2 '17Q3 '17Q4 '17Q1 '18Q2 '18Q3 '18Q4 '18Q1 '19Q2 '19Q3 '19Q4 '19Q1 '20Q2 '20Q3 '20Q4 '20Q1 '21Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

Operating cash flow

5Y CAGR +16.7%10Y CAGR +2.8%YoY −16.2%
$18.7B TTM$6.6B Q3 '26
FY15FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25TTM
Q4 '16Q1 '17Q2 '17Q3 '17Q4 '17Q1 '18Q2 '18Q3 '18Q4 '18Q1 '19Q2 '19Q3 '19Q4 '19Q1 '20Q2 '20Q3 '20Q4 '20Q1 '21Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

Capital expenditure

5Y CAGR −1.5%10Y CAGR +12.4%YoY +5.4%
$4B TTM$1B Q3 '26
FY15FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25TTM
Q4 '16Q1 '17Q2 '17Q3 '17Q4 '17Q1 '18Q2 '18Q3 '18Q4 '18Q1 '19Q2 '19Q3 '19Q4 '19Q1 '20Q2 '20Q3 '20Q4 '20Q1 '21Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

Free cash flow

5Y CAGR +31.1%10Y CAGR +0.9%YoY −19.3%
$14.7B TTM$5.5B Q3 '26
FY15FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25TTM
Q4 '16Q1 '17Q2 '17Q3 '17Q4 '17Q1 '18Q2 '18Q3 '18Q4 '18Q1 '19Q2 '19Q3 '19Q4 '19Q1 '20Q2 '20Q3 '20Q4 '20Q1 '21Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

Shares (diluted)

5Y −1.3%10Y −11.8%YoY −0.8%
2.5B TTM2.5B Q3 '26
FY15FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25TTM
Q4 '16Q1 '17Q2 '17Q3 '17Q4 '17Q1 '18Q2 '18Q3 '18Q4 '18Q1 '19Q2 '19Q3 '19Q4 '19Q1 '20Q2 '20Q3 '20Q4 '20Q1 '21Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

Dividend per share

5Y CAGR +5.8%10Y CAGR +6.1%YoY +4.9%
$3.40 TTM$0.85 Q3 '26
FY15FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25TTM
Q4 '16Q1 '17Q2 '17Q3 '17Q4 '17Q1 '18Q2 '18Q3 '18Q4 '18Q1 '19Q2 '19Q3 '19Q4 '19Q1 '20Q2 '20Q3 '20Q4 '20Q1 '21Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Every MRK chart on Trends →

Shares outstanding (point-in-time)

2024-09 2.53B2024-12 2.53B2025-03 2.51B2025-06 2.50B2025-09 2.48B2025-12 2.47B2026-03 2.47B2026-06 2.47B2026-09 2.47B-2.5% over 8 periods

SEC-filed end-of-period counts (cover pages and balance sheets, split-adjusted) — the series realized buyback yield is computed from. The weighted-average share lines in the statements below lag these by design: an average over the year sits near the midpoint of an ongoing buyback.

PeriodRangeOrderChangeFiguresAs-reported fiscal years.
Line itemTrendFY2025FY2024FY2023FY2022FY2021
Income Statementas ofDec 31 ’25as ofDec 31 ’24as ofDec 31 ’23as ofDec 31 ’22as ofDec 31 ’21
Revenue65.0B+1.3%64.2B+6.7%60.1B+1.4%59.3B+21.7%48.7B+17.3%
48.6B-0.7%49.0B+11.3%44.0B+5.1%41.9B+19.4%35.1B+25.7%
Cost of revenue16.4B+7.8%15.2B-5.8%16.1B-7.4%17.4B+27.8%13.6B+0.1%
Research & development15.8B-12.0%17.9B-41.2%30.5B+125.4%13.5B+10.6%12.2B-8.6%
Selling, general & administrative10.7B-0.8%10.8B+3.0%10.5B+4.6%10.0B+4.2%9.63B+7.6%
Restructuring889M+187.7%309M-48.4%599M+77.7%337M-49.0%661M+15.0%
Amortization of intangibles2.80B+16.7%2.40B+20.0%2.00B-4.8%2.10B+31.3%1.60B-11.1%
Interest expense1.36B+6.8%1.27B+10.9%1.15B+19.1%962M+19.4%806M-3.0%
Interest & investment income343M-17.3%415M+13.7%365M+132.5%157M+336.1%36.0M-39.0%
Other non-operating income-151M-729.2%24.0M+105.2%-466M+69.0%-1.50B-211.9%1.34B+50.7%
Gain (loss) on equity securities368M+2528.6%14.0M-95.9%340M+124.0%-1.42B-173.1%1.94B+45.0%
Pre-tax income21.1B+5.7%19.9B+955.4%1.89B-88.5%16.4B+18.5%13.9B+136.7%
Income tax2.80B+0.0%2.80B+85.4%1.51B-21.2%1.92B+26.1%1.52B+13.5%
18.3B+6.6%17.1B+4589.6%365M-97.5%14.5B+11.3%13.0B+84.6%
Income from continuing operations——365M-97.5%14.5B+17.6%12.3B+173.2%
Discontinued operations
————707M-72.4%
Net income to non-controlling interest9.00M-43.8%16.0M+33.3%12.0M+71.4%7.00M-56.3%16.0M+6.7%
Net income to common18.3B+6.6%17.1B+4589.6%365M-97.5%14.5B+11.3%13.0B+84.6%
$7.28+8.0%$6.74+4714.3%$0.14-97.5%$5.71+11.1%$5.14+84.9%
EPS (basic)$7.30+8.0%$6.76+4728.6%$0.14-97.6%$5.73+11.0%$5.16+84.9%
Weighted-avg shares (basic)2.50B-1.2%2.53B-0.2%2.54B+0.2%2.53B+0.1%2.53B+0.0%
Weighted-avg shares (diluted)2.51B-1.3%2.54B-0.2%2.55B+0.2%2.54B+0.2%2.54B-0.1%
Dividends per share$3.28+5.1%$3.12+5.4%$2.96+5.7%$2.80+6.1%$2.64+6.5%
Balance Sheetas ofDec 31 ’25as ofDec 31 ’24as ofDec 31 ’23as ofDec 31 ’22as ofDec 31 ’21
43.5B+12.2%38.8B+20.6%32.2B-9.9%35.7B+18.0%30.3B+9.0%
Cash & equivalents14.6B+10.0%13.2B+93.6%6.84B-46.1%12.7B+56.8%8.10B+0.6%
Short-term investments0.00-100.0%447M+77.4%252M-49.4%498M0.00
Accounts receivable11.8B+14.6%10.3B-0.7%10.3B+9.5%9.45B+2.4%9.23B+35.7%
Inventory6.66B+9.0%6.11B-3.9%6.36B+7.6%5.91B-0.7%5.95B+7.2%
Other current assets10.5B+20.8%8.71B+4.0%8.37B+16.7%7.17B+2.6%6.99B+49.5%
137B+16.9%117B+9.8%107B-2.3%109B+3.3%106B+15.4%
Property, plant & equipment25.3B+6.5%23.8B+3.2%23.1B+7.6%21.4B+11.1%19.3B+13.4%
Operating lease right-of-use1.51B+10.0%1.37B-4.7%1.44B+6.8%1.35B-15.1%1.59B-6.0%
Goodwill21.6B-0.4%21.7B+2.2%21.2B-0.0%21.2B-0.3%21.3B+12.6%
Intangible assets26.7B+63.0%16.4B-9.1%18.0B-11.1%20.3B-11.6%22.9B+62.6%
Long-term investments956M+106.5%463M+83.7%252M-75.2%1.01B+174.3%370M-52.9%
Other non-current assets18.8B+17.3%16.0B+33.7%12.0B+25.9%9.53B—
28.3B-0.3%28.4B+10.6%25.7B+6.0%24.2B+1.5%23.9B-12.6%
Accounts payable4.40B+8.0%4.08B+4.0%3.92B-8.0%4.26B-7.5%4.61B+6.5%
Short-term & current debt2.59B-2.3%2.65B+93.1%1.37B-29.5%1.95B-19.3%2.41B-62.5%
Current lease liability294M+4.3%282M-1.1%285M+1.4%281M-7.6%304M+4.5%
Other current liabilities14.5B-7.8%15.7B-0.5%15.8B+11.3%14.2B+2.2%13.9B+13.5%
84.2B+19.0%70.7B+2.5%69.0B+9.4%63.1B-6.4%67.4B+1.9%
Long-term debt46.8B+35.7%34.5B+2.3%33.7B+17.2%28.7B-6.3%30.7B+21.0%
Non-current lease liability901M+2.7%877M-5.5%928M-8.4%1.01B-17.3%1.23B-8.2%
Operating lease liability (total)1.20B+3.1%1.16B-4.5%1.21B-6.3%1.29B-15.4%1.53B-6.0%
Deferred tax liabilities1.44B+3.7%1.39B+59.2%871M-51.5%1.79B-47.8%3.44B+242.4%
Other non-current liabilities7.69B+18.9%6.46B-26.5%8.79B+5.6%8.32B-11.8%9.43B-23.3%
52.6B+13.6%46.3B+23.2%37.6B-18.3%46.0B+20.4%38.2B+50.8%
Common stock1.79B+0.0%1.79B+0.0%1.79B+0.0%1.79B+0.0%1.79B+0.0%
Additional paid-in capital45.0B+0.7%44.7B+0.4%44.5B+0.3%44.4B+0.3%44.2B+11.7%
Retained earnings73.1B+15.9%63.1B+17.0%53.9B-11.8%61.1B+13.8%53.7B+13.4%
Treasury stock63.0B+8.1%58.3B+1.5%57.5B+1.7%56.5B-1.1%57.1B+0.6%
Accumulated other comprehensive income-4.29B+13.3%-4.95B+4.2%-5.16B-8.2%-4.77B-7.7%-4.43B+33.2%
Non-controlling interest56.0M-5.1%59.0M+9.3%54.0M-19.4%67.0M-8.2%73.0M-16.1%
Total equity incl. non-controlling52.7B+13.6%46.4B+23.2%37.6B-18.3%46.1B+20.4%38.3B+50.6%
Total liabilities & equity137B+16.9%117B+9.8%107B-2.3%109B+3.3%106B+15.4%
Common shares issued3.58B+0.0%3.58B+0.0%3.58B+0.0%3.58B+0.0%3.58B+0.0%
Common shares outstanding2.47B-2.1%2.53B-0.2%2.53B-0.2%2.54B+0.4%2.53B-0.1%
Shares outstanding (cover)2.47B-2.1%2.53B-0.3%2.53B-0.2%2.54B+0.4%2.53B-0.1%
Treasury shares1.10B+5.1%1.05B+0.4%1.05B+0.6%1.04B-1.0%1.05B+0.3%
Cash Flowas ofDec 31 ’25as ofDec 31 ’24as ofDec 31 ’23as ofDec 31 ’22as ofDec 31 ’21
16.5B-23.3%21.5B+65.1%13.0B-31.9%19.1B+45.5%13.1B+72.3%
Depreciation & amortization5.84B+29.8%4.50B+16.2%3.87B-0.9%3.91B+21.6%3.21B-7.8%
Intangible amortization2.80B+16.7%2.40B+20.0%2.00B-4.8%2.10B+31.3%1.60B-11.1%
Share-based compensation820M+7.8%761M+18.0%645M+19.2%541M+12.9%479M+8.6%
Deferred income taxes-1.67B-33.8%-1.25B+34.2%-1.90B-21.1%-1.57B-938.5%187M+133.0%
Change in receivables1.09B+346.7%244M-78.7%1.15B+78.3%644M-68.3%2.03B+102.9%
Change in inventory1.18B+41.3%835M+2.3%816M+406.8%161M-76.1%674M-24.7%
-13.7B-77.7%-7.73B+45.1%-14.1B-183.9%-4.96B—
Capital expenditure4.11B+21.9%3.37B-12.7%3.86B-12.0%4.39B-1.3%4.45B+0.4%
Free cash flow12.4B-31.7%18.1B+97.9%9.14B-37.8%14.7B+69.6%8.67B+172.1%
Acquisitions10.0B0.000.000.00-100.0%179M-86.9%
Purchases of investments1.21B+132.6%519M-45.7%955M-20.7%1.20B+120300.0%1.00M
Sales/maturities of investments———721M-29.7%1.03B-63.5%
Other investing activities58.0M-54.3%127M+252.8%36.0M-59.6%89.0M-2.2%91.0M+172.8%
-1.92B+72.7%-7.03B-46.2%-4.81B+47.3%-9.12B—
Long-term debt issued13.9B+285.7%3.60B-39.4%5.94B0.00-100.0%7.94B+79.6%
Long-term debt repaid2.50B+94.0%1.29B-26.5%1.75B-22.0%2.25B-2.9%2.32B+18.5%
Net short-term debt———0.00+100.0%-3.99B-256.4%
Common stock issued0.000.000.000.000.00
Common stock repurchased5.08B+289.3%1.31B-3.0%1.35B0.00-100.0%840M-34.4%
Dividends paid8.18B+4.3%7.84B+5.3%7.45B+6.2%7.01B+6.1%6.61B+6.4%
Other financing activities-131M+64.8%-372M-13.4%-328M-36.7%-240M+16.1%-286M+34.4%
FX effect on cash563M+292.2%-293M-1373.9%23.0M+105.6%-410M-208.3%-133M-152.6%
Net change in cash1.37B-78.6%6.41B+209.3%-5.86B-227.3%4.61B+32800.0%14.0M+100.8%
Interest paid1.30B+0.0%1.30B+18.2%1.10B+17.4%937M+20.3%779M-5.2%
Income taxes paid6.09B+54.9%3.93B-9.5%4.34B+33.9%3.24B+34.3%2.41B-12.0%
Valuation Ratiosas ofDec 31 ’25as ofDec 31 ’24as ofDec 31 ’23as ofDec 31 ’22as ofDec 31 ’21
Market cap260B+3.6%251B-9.0%276B-1.8%281B+45.2%194B-1.9%
P/E14.3×-2.9%14.7×-75.5%60.0×+225.2%18.4×+24.2%14.8×-46.9%
P/S4.0×+2.2%3.9×-15.9%4.7×-2.4%4.8×+19.9%4.0×-16.4%
P/B5.0×-8.8%5.4×-18.9%6.7×+5.9%6.3×+24.7%5.1×-35.0%
P/FCF21.1×+51.7%13.9×-33.8%21.0×+14.2%18.4×-17.7%22.3×-63.9%
Earnings yield7.0%+2.9%6.8%+308.1%1.7%-69.3%5.4%-19.5%6.7%+88.2%
FCF yield4.7%-34.1%7.2%+51.0%4.8%-12.4%5.4%+21.6%4.5%+177.4%
Dividend yield3.1%-0.6%3.1%+15.5%2.7%+7.6%2.5%-26.7%3.4%+8.4%
Source filing10-K10-K10-K10-K10-K
Fiscal yearCEOTotal, as reportedActually paidOther executives, average$100 in the stock$100 in peers
FY2025Mr. Davis$20.8M$15.8M$6.9M$158.08$198.33
FY2024Mr. Davis$23.2M$14.7M$9.5M$144.00$145.51
FY2023Mr. Davis$20.3M$26.7M$7.6M$153.61$134.12
FY2022Mr. Davis$18.7M$52.5M$8.4M$152.09$130.07
FY2021Mr. Davis $13.7M / $14.4MMr. Frazier $15.2M / $13.3M$28.9M$27.7M$6.7M$101.81$122.48
FY2020Mr. Frazier$22.1M$10.6M$6M——

From the pay-versus-performance table of each proxy statement (DEF 14A), the newest that states the year. “Actually paid” values stock awards at the year’s closing price, so it falls when the stock does. A year two chief executives shared lists each one’s pay, as reported / actually paid, and the totals are both. $100 in the stock and in the peer group the proxy names are the newest proxy’s, from the start of its first year.

About this data

Source: MRK’s SEC filings (10-K / 10-Q). Annual columns are as-reported fiscal years; quarterly columns are as-reported fiscal quarters (Q4 derived as full-year minus the first three quarters where a company doesn’t file a standalone Q4); TTM (quarterly) rolls the trailing four quarters at every quarter end, TTM (yearly) samples that one year apart; balance-sheet rows show the period-end balance. Valuation ratios are sampled as of each period end. View all MRK filings on SEC EDGAR → Not investment advice.